Colleges, employers, and the military all use aptitude tests to predict how well someone might do. In recent years, some critics of these tests have said there isn’t much difference in performance above a certain level-that, above a certain threshold, everyone is more or less the same…
We know that poor social and physical environments can harm young children’s cognitive and behavioral development, and that development often improves in better environments…
We know that poor social and physical environments can harm young children’s cognitive and behavioral development, and that development often improves in better environments…
Imagining something with our mind’s eye is a task we engage in frequently, whether we’re daydreaming, conjuring up the face of a childhood friend, or trying to figure out exactly where we might have parked the car…
A brain implant developed at the University of Michigan uses the body’s skin like a conductor to wirelessly transmit the brain’s neural signals to control a computer, and may eventually be used to reactivate paralyzed limbs.
The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that is designed to improve the quality and safety of treatment provided to more than 25,000 Medicare beneficiaries who receive care at Community Mental Health Centers (CMHCs) each year. The notice of proposed rulemaking would establish conditions of participation (CoPs) for CMHCs for the first time…
New research finds that men’s conspicuous spending is driven by the desire to have uncommitted romantic flings. And, gentlemen, women can see right through it.
Youths in groups or gangs choose to own dogs primarily for socializing and companionship. Dogs are also used for protection and enhancing status, but to a lesser extent, contrary to popular perception.
Magical thinking, usually dismissed as naive and irrational, can actually help consumers cope with stressful situations like trying to lose weight, according to a new study in the Journal of Consumer Research…
Alkermes, Inc. (NASDAQ: ALKS) today announced the initiation of a phase 1/2 study of ALKS 5461 for treatment-resistant depression (TRD). ALKS 5461 is the combination of ALKS 33, a proprietary opioid modulator, and buprenorphine. TRD, which is also known as refractory depression, refers to depressive episodes that are not adequately controlled by standard antidepressant therapy…
